Category Archives: Stem Cell Clinical Trials

To use this resource, simply select the condition you are interested in from the categories displayed in the menu. For example, if you are interested in trials for Macular Degeneration, then select 'Vision loss' and 'Macular Degeneration' from the drop down menu.If the condition you are interested in is not listed, please use the search function on the USNIH Clinical Trials website. This website provides information about current or recently completed stem cell clinical trials but to find out more about each trial click on the 'Link to Clinical Registry' button. You can also click here to see a summary of the stem cell clinical trials in Australia. It is important to remember that just because a treatment is being evaluated as part of a clinical trial, that does not make it a proven safe and effective therapy. These trials are experimental. Visit What are clinical trials? to learn more. Please use this listing for your research, but continue to speak to your treating Australiandoctors for independent advice on what is best for you. View post: Stem Cell Clinical Trials - Stem Cells Australia … Continue reading →

China's Stem Cell Tech Development--CCTV News China's stem cell research ranks the 3rd-highest number of ongoing stem cell clinical trials in the world. By: Norgen Healthcare International … Continue reading →

One of the more exciting aspects of FFBs recent annual conference, VISIONS 2013, was the news on the clinical development of several emerging stem cell therapies. The field has picked up a lot of steam, with many new human studies of stem-cell treatments anticipated to begin in 2014 and 2015. Whats particularly noteworthy is that some of these trials will be for people with retinitis pigmentosa (RP) a population not yet included in human stem-cell studies. Also, investigators will evaluate new types of cells and new, innovative approaches to implanting them. Heres a review of three of the stem-cell clinical studies on the horizon: Riken Institute: Sheets of RPE Derived from Induced Pluripotent Stem Cells In June, the Japanese Health Ministry gave approval to the Riken Institute to launch a clinical trial of sheets of retinal pigment epithelial (RPE) cells for the treatment of wet age-related macular degeneration (AMD). The study is planned for 2014. The sheets will replace native RPE cells damaged by leaky blood vessels, which are the hallmark of wet AMD. RPE cells play a critical role in supporting photoreceptors, the cells that make vision possible. For the first time in a human study, the researchers will … Continue reading →

Spinal Cord Injury and Stem Cell Clinical Trials: Whats the Latest? Join California's Stem Cell Agency (CIRM) for a live Google Hangout about the latest progress in stem cell-based treatments for spinal cord injury. You don't need a Google+ account to watch... By: California Institute for Regenerative Medicine … Continue reading →

The therapeutic potential of stem cells has so profoundly changed the landscape of medical research that it has spawned an entirely new field regenerative medicine. There is indeed a great deal of promise, but also a tendency to think that a cure is just around the corner. The path from research to the clinic is often long and complicated, with many small advances. Our aim is to present an objective view of the most important advances, to provide a foundational knowledge against which to read and evaluate new research as it emerges. A recent Canadian report examined the state of novel stem cell clinical trials around the world. Find out more here. Generally, it is helpful to understand four different approaches to using stem cells for clinical benefit, in addition to their still critical role in understanding the disease process. Stem cell transplantation Cellular therapy Tissue regeneration Drug discovery General information on clinical trials Where can I find out about ongoing stem cell therapies or clinical trials? Stem cell transplantation exploits the special characteristics of stem cells to multiply indefinitely and to become other cells required by the body. For example, stem cells that reside in the bone marrow or … Continue reading →

Promising Research Promising research and progress underscores the need to increase funding for adult stem cell research. Here youll find the best of the best in current adult stem cell research. This section will keep you up to date on ongoing research and new findings. If youre interested in participating in a clinical trial, please visit ClinicalTrials.gov and perform a search using the terms relevant to your situation. Additionally, you can check the List of Treatable Conditions link, scroll to the bottom of the section and click any links we have found to be helpful regarding this condition/disease. In some cases a link may already be available to perform an automatic search on ClinicalTrials.gov. Unfortunately, at this time the National Stem Cell Foundation is only able to fund research. NSCF is unable to fund patient participation in a clinical trial on an individual basis. A word about clinical trials: Medical research studies involving people are called clinical trials. Clinical trials look at Trials aim to find out if a new experimental drug or procedure New treatments have to be thoroughly tested. A new drug, for example is investigated first in the laboratory. If it looks promising, it is carefully studied … Continue reading →

Matt Valente Interview w/ Dr. Wise Young @WMKECK Center Rutgers University An excerpt from an interview I held with Dr. Wise Young of Rutgers Universities WMKECK Center. Stem Cell Clinical Trials Need to be conducted in the USA! The... By: Matt Valente … Continue reading →

Stem cell science is commonly subject to widely varying treatment at the hands of the media and this is due, in part, to a poor understanding in general of the importance of clinical trials and proper research in the pursuit of knowledge prior to application of a new treatment modality. Clinics offering stem cell therapy often rely on the vulnerability of many patients and their poor understanding of science in order to bamboozle them with faux-science and convince them of the unproven merits of their expensive treatments. Who amongst us is likely to confess ignorance when facing a seemingly qualified doctor in a hospital-like setting discussing matters often of life and death? To ask for clinical evidence and raw data of a treatments efficacy is unlikely to get you very far in most cases, and even if the data were provided would you be any better equipped to make an informed choice about medical treatment? What is a clinical trial, how do they help us in real life, and can they be dangerous? Read on about: The Importance of Clinical Trials See the original post: Stem Cell Clinical Trials | Stem Cell Research … Continue reading →

Los Angeles - July 24, 2013 Timothy D. Henry, MD, an expert known for his innovative work in developing stem cell treatments for advanced heart disease patients, has joined the Cedars-Sinai Heart Institute as director of Cardiology. Henry comes to Cedars-Sinai from Minneapolis, where he was director of research for the Minneapolis Heart Institute Foundation and professor of medicine at the University of Minnesota School of Medicine. As Henry begins his tenure, Prediman K. Shah, MD, the renowned cardiologist who has led the Division of Cardiology for nearly 20 years, is stepping down to focus on patient care and on basic and clinical research, including his quest to develop a vaccine and mutant-gene-based therapies that would thwart heart attacks by preventing and possibly reversing arterial cholesterol buildup. Shah, the Shapell and Webb Family Chair in Clinical Cardiology, director of the Oppenheimer Atherosclerosis Research Center and director of the Atherosclerosis Prevention and Treatment Center, also will continue treating patients and teaching medical residents and cardiology trainees. Dr. Shah has been a wonderful colleague and a highly respected national leader, accelerating the pre-eminence of our Cardiology Division, and Dr. Henry will be starting his new position from a robust platform built over … Continue reading →

Cord Blood Registry Call our Specialists Meet Heather Connecting clients to the regenerative potential of stem cell medicine In addition to current, FDA-regulated clinical trials, the same types of stem cells that are found in cord blood and cord tissue are being used in early-stage research. Although researchers can't say what these studies will yield, newborn stem cells are demonstrating a growing range of potential uses across a variety of therapeutic areas. Stroke Mesenchymal stem cells found in cord tissue are being evaluated in animal studies for their ability to treat ishemic stroke, a condition that occurs when an artery to the brain is blocked. Animals treated with cord tissue stem cells experienced a decrease in the size of injury, with increased blood flow to the affected area. Treated animals also experienced increased motor control, likely due to the stem cells' ability to secrete factors that promote blood flow and encourage the brain's natural healing process.16 Parkinson's DiseaseEarly laboratory studies suggest that mesenchymal stem cells from cord tissue can help improve motor function in animals afflicted with Parkinson's disease, a disorder of the nervous system that affects movement. The study indicated that the stem cells reduced some functional effects of … Continue reading →